NASDAQ · Biotechnology

Neonc Technologies Holdings, Inc. (NTHI) Stock

$3.44 +0.29% NASDAQ: NTHI Healthcare

NeOnc Technologies Holdings, Inc. is a clinical-stage biopharmaceutical company.

Valuation

MetricValue
Price$3.44
Market Cap$89.21M
P/E Ratio-1.77
P/B Ratio-6.04
P/S Ratio2750.00
EPS (TTM)$-3.23
52-Week High$12.99
52-Week Low$3.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE284.28%
ROA-2066.67%
ROCE257.73%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity-0.03
Current Ratio0.05

Annual Financials (USD)

Metric2025
Revenue$0
Operating Profit$-58.0M
Net Profit$-62.0M
EPS$-3.23
Op Margin-145459.4%

Balance Sheet (USD)

Metric2025
Total Assets$3.0M
Total Liabilities$20.0M
Cash$0
Borrowings$6.0M

Latest News

NeOnc Receives FDA Written Feedback on NEO212 CMC Development and Capsule-to-Tablet Transition Stocktwits · Jul 15, 2026 NeOnc Technologies Receives UAE IND Approval for NEO100, Expanding Global Development Ahead of Anticipated Phase 2 Data Milestone Stocktwits · Jun 23, 2026 WSTPR Catalyst Watch: Abu Dhabi Regulatory Clearance Adds Momentum to NeOnc's Global Neuro-Oncology Strategy TMX Newsfile · Jun 22, 2026 NeOnc Technologies Secures UAE IND Approval for NEO212 Following Successful Phase 1 Completion, Advancing Toward Global Phase 2 Development Stocktwits · Jun 16, 2026 WSTPR Catalyst Watch: NeOnc Strengthens Capital Position Ahead of Potentially Transformational Neuro-Oncology Updates TMX Newsfile · Jun 15, 2026

Cash Flow (USD)

Metric2025
Operating Cash Flow$-20.0M
Investing Cash Flow$-1.0M
Financing Cash Flow$0
Net Cash Flow$0
Free Cash Flow$-21.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.07
EV / EBITDA-2.55
FCF Yield-23.54%
Quick Ratio0.05
Interest Coverage-19.33
Return 1Y-15.10%
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About Neonc Technologies Holdings, Inc.

NeOnc Technologies Holdings, Inc. is a clinical-stage biopharmaceutical company. It develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company was founded in 2008 and is headquartered in Calabasas, CA.

Neonc Technologies Holdings, Inc. is led by CEO Amir Farrokh Heshmatpour, employs 8 people, headquartered in US, publicly traded since 2025.

Neonc Technologies Holdings, Inc. (NTHI) stock trades at $3.44 with a market capitalization of $89.21M. The stock is valued at a price-to-earnings (P/E) ratio of -1.77, price-to-book of -6.04, price-to-sales of 2750.00. Over the past 52 weeks the stock has ranged between $3.00 and $12.99, and currently trades 73.5% below its 52-week high.

On profitability, Neonc Technologies Holdings, Inc. generates a return on equity (ROE) of 284.28% — well above the market average, a sign of a high-quality business, return on capital employed of 257.73%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: www.neonctech.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides